Probiotic therapy with Saccharomyces boulardii for heart failure patients: a randomized, double-blind, placebo-controlled pilot trial
AC Costanza, SD Moscavitch…�- International�…, 2015 - internationaljournalofcardiology.com
On the last decade, there has been a progressive increase in a number of publications on
microbiota and therapeutic potential of probiotics. Recent studies have been suggesting that
consuming probiotics may have benefits on cardiovascular system, as the improvement on
blood pressure control by a modest degree [1]. Heart failure (HF) patients present low grade
inflammation that participates on the progression of cardiac remodeling [2]. Moreover, when
the heart is failing, myocytes show enhanced expression of inflammatory mediators, as�…
microbiota and therapeutic potential of probiotics. Recent studies have been suggesting that
consuming probiotics may have benefits on cardiovascular system, as the improvement on
blood pressure control by a modest degree [1]. Heart failure (HF) patients present low grade
inflammation that participates on the progression of cardiac remodeling [2]. Moreover, when
the heart is failing, myocytes show enhanced expression of inflammatory mediators, as�…